{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:19:43Z","timestamp":1791062383601,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":27,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd007560.pub2","type":"reference-entry","created":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T07:13:02Z","timestamp":1246605182000},"source":"Crossref","is-referenced-by-count":7,"title":["Methotrexate for maintenance of remission in ulcerative colitis"],"prefix":"10.1002","author":[{"given":"Wael","family":"El-Matary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Vandermeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD007560.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1053\/gast.1996.v110.pm8613046","article-title":"Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial","volume":"110","author":"Oren","year":"1996","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD007560.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/BF01296109","article-title":"Low-dose oral methotrexate in refractory inflammatory bowel disease","volume":"38","author":"Baron","year":"1993","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1002\/14651858.CD007560.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2036.2005.02331.x","article-title":"Oral methotrexate in ulcerative colitis","volume":"21","author":"Cummings","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1002\/14651858.CD007560.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1046\/j.1365-2036.1999.00667.x","article-title":"A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis","volume":"13","author":"Egan","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1002\/14651858.CD007560.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00054725-200011000-00005","article-title":"Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease","volume":"6","author":"Egan","year":"2000","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1002\/14651858.CD007560.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1365-2036.2002.01227.x","article-title":"The efficacy of methotrexate for maintaining remission in inflammatory bowel disease","volume":"16","author":"Fraser","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"4 Suppl 2","key":"10.1002\/14651858.CD007560.pub2-BIB7|cit7","first-page":"A525","article-title":"Subcutaneous methotrexate: a safe and effective therapy in IBD","volume":"130","author":"Gibson","year":"2006","journal-title":"Gastroenterology"},{"issue":"51","key":"10.1002\/14651858.CD007560.pub2-BIB8|cit8","first-page":"2552","article-title":"Methotrexate as possible treatment in refractory chronic inflammatory intestinal disease","volume":"138","author":"Houben","year":"1994","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"5","key":"10.1002\/14651858.CD007560.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-110-5-353","article-title":"Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease","volume":"110","author":"Kozarek","year":"1989","journal-title":"Ann Intern Med"},{"issue":"Suppl","key":"10.1002\/14651858.CD007560.pub2-BIB10|cit10","first-page":"A648","article-title":"Long-term use of methotrexate in inflammatory bowel disease","volume":"102","author":"Kozarek","year":"1992","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD007560.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/00042737-200012110-00010","article-title":"6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease","volume":"12","author":"Mate-Jimenez","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1002\/14651858.CD007560.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1440-1746.2007.05006.x","article-title":"A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration","volume":"23","author":"Nathan","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"10.1002\/14651858.CD007560.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1046\/j.1365-2036.2002.01340.x","article-title":"Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission","volume":"16","author":"Paoluzi","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1002\/14651858.CD007560.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-2036.2003.01480.x","article-title":"Methotrexate in ulcerative colitis","volume":"17","author":"Siveke","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1002\/14651858.CD007560.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00042737-200409000-00018","article-title":"Experience with the use of low-dose methotrexate for inflammatory bowel disease","volume":"16","author":"Soon","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1002\/14651858.CD007560.pub2-BIB16|cit16","unstructured":"A controlled randomized double-blinded multicenter study comparing methotrexate to placebo in steroid-refractory ulcerative colitis Ongoing study"},{"issue":"6","key":"10.1002\/14651858.CD007560.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1365-2036.2007.03334.x","article-title":"Review article: the management of steroid dependency in ulcerative colitis","volume":"26","author":"Bianchi Porro","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1002\/14651858.CD007560.pub2-BIB18|cit18","article-title":"Methotrexate for induction of remission in ulcerative colitis","author":"Chande","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD007560.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199502023320503","article-title":"Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators","volume":"332","author":"Feagan","year":"1995","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1002\/14651858.CD007560.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM200006013422202","article-title":"A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators","volume":"342","author":"Feagan","year":"2000","journal-title":"N Eng J Med"},{"issue":"3","key":"10.1002\/14651858.CD007560.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00042737-200303000-00003","article-title":"Methotrexate: first-line or second-line immunomodulator?","volume":"15","author":"Fraser","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"10.1002\/14651858.CD007560.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/01.fpc.0000172242.19675.33","article-title":"The pharmacogenetics of methotrexate in inflammatory bowel disease","volume":"15","author":"Herrlinger","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1002\/14651858.CD007560.pub2-BIB23|cit23","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184.ch8","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008)","author":"Higgins","year":"2008"},{"issue":"5","key":"10.1002\/14651858.CD007560.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0049-0172(94)90027-2","article-title":"Low-dose methotrexate in rheumatic disease -- efficacy, side effects, and risk factors for side effects","volume":"23","author":"Schnabel","year":"1994","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1002\/14651858.CD007560.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1572-0241.2003.07305.x","article-title":"Low dose methotrexate in inflammatory bowel disease: current status and future directions","volume":"98","author":"Schroder","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1002\/14651858.CD007560.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1111\/j.1572-0241.2000.03287.x","article-title":"Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease","volume":"95","author":"Te","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1002\/14651858.CD007560.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1111\/j.1572-0241.2007.01474.x","article-title":"Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn disease","volume":"102","author":"Turner","year":"2007","journal-title":"Am J Gastroenterol"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007560.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T00:00:00Z","timestamp":1439251200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007560.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:11:29Z","timestamp":1628532689000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007560.pub2"}},"subtitle":[],"editor":[{"given":"Wael","family":"El-Matary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,7,8]]},"references-count":27,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007560.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD007560.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2009,7,8]]}}}